Filter Results
:
(5,704)
Show Results For
-
All HBS Web
(5,704)
- People (18)
- News (1,267)
- Research (3,521)
- Events (19)
- Multimedia (41)
- Faculty Publications (2,121)
Show Results For
-
All HBS Web
(5,704)
- People (18)
- News (1,267)
- Research (3,521)
- Events (19)
- Multimedia (41)
- Faculty Publications (2,121)
- 01 Nov 2019
- Video
James Mwangi
James Mwangi, CEO and Managing Director of CBS Group and Equity Group Holdings, discusses innovation in microfinance business models in Kenya.
View Details
- 24 Apr 2024
- News
What Managers Can Learn from Jazz Improvisation
- Teaching Interest
Agribusiness Seminar - Executive Education
By: David E. Bell
In the agribusiness industry, every year brings new trends and challenges. While demand continues to grow, consumer needs shift, production challenges increase, and evolving technology impacts every part of the value chain. The complex...
View Details
- August 2019 (Revised March 2022)
- Case
Lemonade: Disrupting Insurance with Instant Everything, Killer Prices, and a Big Heart
By: Elie Ofek and Danielle Golan
Launching its first products in the fall of 2016 in New York, insurtech startup Lemonade was on a mission to disrupt the insurance market by using AI and behavioral economics principles. The company offered renters, homeowners, and condo insurance and mainly targeted...
View Details
Keywords:
AI;
Business Startups;
Insurance;
Technological Innovation;
Business Model;
Disruption;
Brands and Branding;
Growth and Development Strategy;
Global Strategy;
Decision Making;
Insurance Industry;
Technology Industry
Ofek, Elie, and Danielle Golan. "Lemonade: Disrupting Insurance with Instant Everything, Killer Prices, and a Big Heart." Harvard Business School Case 520-020, August 2019. (Revised March 2022.)
Alberto F. Cavallo
Alberto Cavallo is the Thomas S. Murphy Professor of Business Administration at Harvard Business School, where he teaches in the Business, Government, and the International Economy (BGIE) unit, a Faculty Research Fellow at the National Bureau of Economic Research, a... View Details
- February 2021 (Revised May 2021)
- Case
SafeGraph: Selling Data as a Service
By: Ramana Nanda, Abhishek Nagaraj and Allison Ciechanover
Set in January 2021, the CEO of SafeGraph, a four-year-old startup that sold Data as a Service, looked to the future. His aim was to become the most trusted source for data about a physical place. The company provided points of interest (POI) and foot traffic data on...
View Details
Keywords:
Data As A Service;
Monetization;
Pricing;
Business Startups;
Analytics and Data Science;
Consumer Behavior;
Analysis;
Business Model;
Health Pandemics;
Information Industry;
United States
Nanda, Ramana, Abhishek Nagaraj, and Allison Ciechanover. "SafeGraph: Selling Data as a Service." Harvard Business School Case 821-082, February 2021. (Revised May 2021.)
- February 2000 (Revised November 2002)
- Case
QuickenInsurance: The Race to Click and Close (A)
ES Technologies started in 1976 as a storefront in Tempe, Arizona selling personal computer kits to hobbyists. Twenty years later, revenues exceeded $3.5 billion, and the business had evolved from a computer store to a master reseller and full-line integrator of...
View Details
Keywords:
Customer Value and Value Chain;
Entrepreneurship;
Technological Innovation;
Growth and Development Strategy;
Industry Structures;
Business Strategy;
Competitive Strategy;
Information Technology;
Information Technology Industry;
Arizona
Applegate, Lynda M. "QuickenInsurance: The Race to Click and Close (A)." Harvard Business School Case 800-295, February 2000. (Revised November 2002.)
- November 1997 (Revised May 1999)
- Case
Medical Foods, Inc.
By: Ray A. Goldberg and Tom Clay
Dr. Franklin Lowe is CEO of a new kind of company in a new kind of industry--medical foods. He must select a business model and partners that will help make this a viable business.
View Details
Keywords:
Business Model;
Partners and Partnerships;
Business or Company Management;
Strategy;
Business Startups;
Health Care and Treatment;
Food;
Innovation and Management;
Food and Beverage Industry;
Health Industry
Goldberg, Ray A., and Tom Clay. "Medical Foods, Inc." Harvard Business School Case 598-048, November 1997. (Revised May 1999.)
- June 1997 (Revised March 2001)
- Case
Genset Initial Public Offering (A)
By: Paul A. Gompers and Jeffrey M. Anapolsky
Pascal Brandys, founder and CEO of Genset, must decide whether to take this young biotechnology company public. If so, should he do a dual offering in both France and the U.S.? The case also explores the business models in genomics research.
View Details
Keywords:
Business Model;
Initial Public Offering;
Genetics;
Going Public;
Management Teams;
Biotechnology Industry;
France;
United States
Gompers, Paul A., and Jeffrey M. Anapolsky. "Genset Initial Public Offering (A)." Harvard Business School Case 297-096, June 1997. (Revised March 2001.)
- January 2021
- Supplement
mPharma (B)
By: Rembrand Koning, John D. Macomber, Pippa Tubman Armerding and Wale Lawal
mPharma pioneered electronic prescriptions in Ghana, and aimed to increase drug affordability and accessibility in Africa, but the company remained unprofitable. Following investor concerns about mPharma's business, CEO Gregory Rockson considered alternative business...
View Details
Keywords:
Strategy;
Health;
Entrepreneurship;
Business Model;
Health Industry;
Technology Industry;
Ghana
Koning, Rembrand, John D. Macomber, Pippa Tubman Armerding, and Wale Lawal. "mPharma (B)." Harvard Business School Supplement 721-429, January 2021.
Strategies to Fight Ad-sponsored Rivals
We analyze the optimal strategy of a high-quality incumbent that faces a low-quality ad-sponsored competitor. In addition to competing through adjustments of tactical variables such as price or the number of ads a product carries, we allow the incumbent to...
View Details
- September 2003
- Case
Growing Up in China: The Financing of BabyCare Ltd.
By: Mihir A. Desai and Mark Veblen
The CFO of this infant nutritional products company must choose among competing financing offers. The interplay of Chinese legal and customs restrictions and venture capitalists' bargaining techniques challenge the CFO to navigate a tricky negotiation and to devise a...
View Details
Keywords:
Venture Capital;
Working Capital;
Emerging Markets;
Entrepreneurship;
Business Startups;
China
Desai, Mihir A., and Mark Veblen. "Growing Up in China: The Financing of BabyCare Ltd." Harvard Business School Case 204-029, September 2003.
- 06 Jul 2020
- News
Fit for Context Leadership
- February 2021
- Tutorial
What is AI?
By: Tsedal Neeley
This video explores the elements that constitute artificial intelligence (AI). From its mathematical basis to current advances in AI, this video introduces students to data, tools, and statistical models that make a computer 'intelligent.' Through an explanation of...
View Details
- 07 Jul 2008
- Research & Ideas
Innovation Corrupted: How Managers Can Avoid Another Enron
the rewards were great. This initial success prompted Enron to extrapolate its business model to other markets. In 1994, Enron officials started trading wholesale electricity after Congress deregulated the...
View Details
- September 2000 (Revised November 2002)
- Case
Amazon.com: 1994-2000
By: Lynda M. Applegate and Meredith Collura
Enables a thorough analysis of Amazon.com and the company's value proposition, in terms of its business concept, digital business capabilities, and community and shareholder value. Examines the company's complex set of business models and web of business relationships,...
View Details
Keywords:
Entrepreneurship;
Asset Pricing;
Capital;
Financial Strategy;
Technological Innovation;
Business or Company Management;
Growth and Development Strategy;
Business Strategy;
Competitive Strategy;
Information Technology Industry;
Web Services Industry
Applegate, Lynda M., and Meredith Collura. "Amazon.com: 1994-2000." Harvard Business School Case 801-194, September 2000. (Revised November 2002.)
- July 2001 (Revised August 2005)
- Case
Medicines Company, The
It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The...
View Details
Keywords:
Business Model;
Change Management;
Decision Choices and Conditions;
Cost Management;
Price;
Product Marketing;
Product Launch;
Product Development;
Risk and Uncertainty;
Health Industry;
Pharmaceutical Industry
Gourville, John T. "Medicines Company, The." Harvard Business School Case 502-006, July 2001. (Revised August 2005.)
- 2015
- Working Paper
Build It, Buy It or Both? Rethinking the Sourcing of Advertising Services
By: Alvin J. Silk and Marta M. Stiglin
This paper provides an update on the current state of in-house agencies. Whereas traditional consideration of internalizing advertising services was framed as a binary choice of build or buy, today's advertisers frequently pursue hybrid policies of build and buy to...
View Details
Silk, Alvin J., and Marta M. Stiglin. "Build It, Buy It or Both? Rethinking the Sourcing of Advertising Services." Harvard Business School Working Paper, No. 15-093, June 2015.